cbdMD (YCBD) Revenue Growth (3y) (2019 - 2025)
cbdMD (YCBD) Revenue Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.97 Bn | 87.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.26 Bn | 30.32 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 2.94% |
| 10 | cbdMD | 4.88 Mn | 1.50 Mn | 3.00 Mn | -7.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.02% |
| Sep 30, 2025 | -21.01% |
| Jun 30, 2025 | -18.76% |
| Mar 31, 2025 | -20.99% |
| Dec 31, 2024 | -19.65% |
| Sep 30, 2024 | -21.65% |
| Jun 30, 2024 | -23.04% |
| Mar 31, 2024 | -29.44% |
| Dec 31, 2023 | -25.75% |
| Sep 30, 2023 | -27.91% |
| Jun 30, 2023 | -17.28% |
| Mar 31, 2023 | -12.76% |
| Dec 31, 2022 | -15.69% |
| Sep 30, 2022 | -0.94% |
| Jun 30, 2022 | -4.07% |
| Mar 31, 2022 | 7.49% |
| Dec 31, 2021 | 143.38% |
| Sep 30, 2021 | 51.63% |
| Jun 30, 2021 | 83.04% |
| Mar 31, 2021 | 59.22% |